Supplementary Figure S3 from Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader

Authors: Lawrence B. Snyder, Taavi K. Neklesa, Ryan R. Willard et al.
Publication:
Published: Unknown date
Source: Crossref
Back to Search View Original Cite This Article

Abstract

<jats:p>&lt;p&gt;Supplementary Figure S3 shows the effect of bavdegalutamide on SALL4&lt;/p&gt;</jats:p>

Keywords

psupplementary figure shows effect bavdegalutamide

Related Articles

Supplementary material to "Streamflow and satellite evapotranspiration are asymmetric calibration targets in water-limited catchments"

Roland Yonaba, Tazen Fowé et al. - Unknown

Read More
Supplementary Figure 3 from Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model

Marina Ayre, Gonzalo Fernandez-Ugazio et al. - Unknown

Read More
Supplementary material to "ATDT v1.0 – Attribution Tool for Daily-to-monthly Temperatures and its application to record-breaking Northern European heatwave of July 2025"

Antti Toropainen, Mika Rantanen et al. - Unknown

Read More
Supplementary material to "Improving Shortwave Radiative Transfer in the Lake Component of the Common Land Model (CoLM-Lake) with a Spectral Scheme for the Full Snow-Ice-Water Column"

Xueqi Cao, Nan Wei et al. - Unknown

Read More
Within- and between-host dynamics of highly pathogenic avian influenza in domestic birds from Pennsylvania farms and live bird markets

Anna S Jaeger, Elena Cruz-Adames et al. - Unknown

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Centre Research Guides CiteScore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0